(StatePoint) If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you receive can impact your health outcomes and quality of life. That ...
A close up of a 91 year old man using a nebulizer in the glow of the evening light. Once-daily revefenacin when administered via a jet nebulizer with formoterol was well tolerated and associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results